Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Rhea-AI Summary

Amicus Therapeutics (Nasdaq: FOLD) announced that its management will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami, FL, on June 11, 2024, at 4:00 p.m. E.T.

The live audio webcast of the presentation will be accessible via the investors section of the Amicus Therapeutics website. Amicus Therapeutics is a biotechnology firm focused on developing medicines for rare diseases, committed to advancing a pipeline of innovative treatments.

Positive

• Participating in the prestigious Goldman Sachs 45th Annual Global Healthcare Conference enhances the company's visibility.
• Live audio webcast allows for broader investor engagement and transparency.
• Focus on rare diseases positions Amicus Therapeutics in a niche, potentially high-revenue market.

Negative

• The announcement lacks specific updates on financial performance or clinical trial results, which are critical for investors.
• No new product developments or milestone achievements were highlighted.
• Reliance on conferences for visibility may indicate a need for more substantial business developments.

PRINCETON, N.J., June 05, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in a fireside chat at the Goldman Sachs 45^th Annual Global Healthcare Conference in Miami, FL on Tuesday, June 11, 2024, at 4:00 p.m. E.T.

A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on X and LinkedIn.

CONTACT:

Investors:
Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809

Media:
Amicus Therapeutics
Diana Moore
Head of Global Corporate Affairs and Communications
dmoore@amicusrx.com
(609) 662-5079

FOLD–G

FAQ

When will Amicus Therapeutics present at the Goldman Sachs Healthcare Conference?

Amicus Therapeutics will present on June 11, 2024, at 4:00 p.m. E.T.

Where can I access the live audio webcast of Amicus Therapeutics' presentation?

The live audio webcast will be available on the investors section of the Amicus Therapeutics website.

What is the focus of Amicus Therapeutics?

Amicus Therapeutics focuses on developing novel medicines for people with rare diseases.

What stock symbol does Amicus Therapeutics trade under?

Amicus Therapeutics trades under the stock symbol FOLD.